Recon: Gilead Enlists Insitro to Develop Experimental NASH Drugs - R...
04/16/19
Recon: Gilead Enlists Insitro to Develop Experimental NASH Drugs Regulatory Focus
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Gilead teams up with Insitro for experimental NASH ...
[more]